Viking Therapeutics (VKTX) EBITDA (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly EBITDA came in at -$132.6 million in Q2 2026, down 77.81% year-over-year from -$597.4 million in Q2 2025, and up 19.21% quarter-over-quarter from -$164.1 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) EBITDA (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed EBITDA across 13 years of filings, most recently posting -$132.6 million for Q2 2026.
- In Q2 2026, EBITDA fell 77.81% year-over-year to -$132.6 million; the TTM figure through Jun 2026 stood at -$560.0 million (down 163.12% YoY), while the FY2025 annual figure was -$393.3 million, down 160.63% from the prior year.
- EBITDA came in at -$132.6 million for Q2 2026 at Viking Therapeutics, up from -$164.1 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$16.2 million in Q3 2022 to a low of -$164.7 million in Q4 2025.
- Average EBITDA over 5 years is -$56.2 million, with a median of -$34.1 million recorded in 2024.
- Year-over-year, EBITDA slipped 13.45% in 2022 and slumped 256.28% in 2025.
- Over 5 years, EBITDA stood at -$20.3 million in 2022, then sank by 44.38% to -$29.3 million in 2023, then slumped by 57.89% to -$46.2 million in 2024, then tumbled by 256.28% to -$164.7 million in 2025, then increased by 19.51% to -$132.6 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$132.6 million in Q2 2026, -$164.1 million in Q1 2026, and -$164.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | -132.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -132.60 Mn |
| Mar 31, 2026 | -164.13 Mn |
| Dec 31, 2025 | -164.74 Mn |
| Sep 30, 2025 | -98.56 Mn |
| Jun 30, 2025 | -74.57 Mn |
| Mar 31, 2025 | -55.47 Mn |
| Dec 31, 2024 | -46.24 Mn |
| Sep 30, 2024 | -36.56 Mn |
| Jun 30, 2024 | -34.05 Mn |
| Mar 31, 2024 | -34.07 Mn |
| Dec 31, 2023 | -29.29 Mn |
| Sep 30, 2023 | -27.27 Mn |
| Jun 30, 2023 | -23.74 Mn |
| Mar 31, 2023 | -20.54 Mn |
| Dec 31, 2022 | -20.28 Mn |
| Sep 30, 2022 | -16.20 Mn |
| Jun 30, 2022 | -17.63 Mn |
| Mar 31, 2022 | -16.25 Mn |
| Dec 31, 2021 | -12.51 Mn |
| Sep 30, 2021 | -13.40 Mn |
API Access
Viking Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();